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the cervical nodes in patients with thoracic esophageal
carcinoma is associated with distant metastasis (M1).
The conventional thinking is that surgical intervention
is not indicated for patients with such a metastasis. We
have reported the advantage of extensive lymph node
dissection, including the neck, for the survival of
patients with esophageal carcinoma.4 Therefore, in
patients with involved cervical lymph nodes, it is
thought that dissection of the involved lymph nodes
might provide the possibility for radical cure.
In the present retrospective study, we attempted to
determine whether and under what circumstances surgi-
cal intervention should be recommended for patients
with clinically positive cervical nodes for metastasis
from thoracic esophageal carcinoma by pretreatment
examination.
Patients and methods
Radical surgery was attempted as primary treatment in 63
patients of a consecutive 121 patients who were diagnosed as
having positive cervical node involvement from primary car-
cinoma of the thoracic esophagus by pretreatment examina-
tion at the National Cancer Center Hospital, Tokyo, between
D espite recent advances in the treatment ofesophageal cancer, the general prognosis for
patients with this disease remains poor. Most affected
patients are seen at a late stage of the disease. The high
incidence of cervical lymph node involvement in
patients with thoracic esophageal carcinoma is well
known.1 Altorki and Skinner2 recently reported the 35%
prevalence of cervical node metastases in patients who
undergo en bloc or standard esophagectomy. According
to the TNM classification,3 metastatic involvement of
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July 1987 and December 1995. All the patients had a histo-
logic examination of endoscopic biopsy specimens, and
patients with synchronous or a history of head and neck
tumors were excluded. The characteristics of these patients
are listed in Table I. The cervical lymph nodes, including the
bilateral supraclavicular nodes, the lower half of the deep cer-
vical nodes, and the cervical paraesophageal nodes, were
examined for metastasis from the esophageal tumor for pre-
treatment classification. Diagnosis of positive cervical node
involvement in all patients was made by members of the
Department of Surgery, computed tomography and ultra-
sonography.5 All of the patients were examined for synchro-
nous head and neck tumors by members of the Department of
Head and Neck Surgery.
None of the patients had distant organ metastasis. In 60
patients the tumor was considered not to have infiltrated adja-
cent organs. Radical surgery was attempted in 3 patients by a
combined partial resection of the infiltrated lung.6 Six
patients who had intramural metastasis received preoperative
chemotherapy with cisplatin and 5-fluorouracil for neoadju-
vant setting.7 Radical surgery was accomplished with
esophagectomy through the right thoracotomy and 3-field
dissection with dissection of the positive cervical nodes.
Cervical nodes were dissected from exactly the same area
through a collar incision where they were detected before the
operation.
The median follow-up period of censored cases was 44.6
months. In the patients who underwent a radical operation,
the initial recurrence site is analyzed. The postoperative sur-
vivals were compared according to 5 factors: (1) tumor loca-
tion, (2) T categories according to the TNM classification, (3)
subdivisions of N categories classified by the number of
involved nodes, according to the supplement of the TNM
classification,8 (4) the existence of abdominal node involve-
ment in addition to cervical node involvement as an index of
wide lymphatic spread, and (5) R categories of residual tumor
classification according to the TNM classification. The sub-
divisions of N categories were classified as N1a (1 to 3 nodes
involved), N1b (4 to 7 nodes involved), and N1c (more than
7 nodes involved). The definition of R0 was classified as “no
residual tumor.” The survival analysis was not performed
according to stage, because all the patients had metastasis in
cervical lymph node and were classified as stage IV. The
patients with a tumor in the upper thoracic esophagus were
classified as a mean equivalent to stage IVA, and the patients
with tumors in the middle and lower esophagus were classi-
fied as a mean equivalent to stage IVB. Thus the analysis per-
formed with attention to the location on the tumor has the
same mean as that performed with attention to the stage. The
survivals and the survival curves are expressed according to
the Kaplan-Meier method and included patients who died of
operative complications. The difference between the survival
curves was analyzed by the log rank method. The Cox pro-
portional hazards model was used for multivariable analysis
of these factors.
Results
Of 63 patients in whom radical surgery was attempted,
unexpected residual tumors were left during surgery in
14 patients, for primary tumor infiltration to adjacent
structures in 6 patients, for metastatic node invading
adjacent structures in 7 patients, and for unexpected
pulmonary metastasis in 1 patient. By histologic exam-
ination of dissected nodes, 10 patients had involved
nodes only in the neck, and 5 of them had only 1
involved node. Death related to operative complica-
tions was observed in 1 patient.
In 49 patients who underwent radical surgery, cancer
recurrence was found in 33 patients. The initial recur-
Table I. The characteristics of patients with clinically
positive cervical node involvement from thoracic
esophageal carcinoma who underwent an operation
as primary treatment (1987 to 1995; n = 63)
Variable n
Male/female 55/8
Age (y, mean ± SD) 61.3 ± 8.2
Histologic type
Squamous 60
Adenocarcinoma 1
Undifferentiated 2
Tumor location
Upper 13
Middle 44
Lower 6
T categories
T1 8
T2 6
T3 46
T4 3
Table II. The inital recurrent site in patients underwent
an operation without residual tumor (1987 to 1995;
n = 43)
Site n
Local (n = 7)
Bronchial wall 3
Pleura 3
Anastomotic site 1
Lymph node (n = 19)
Cervical 11
Mediastinal 5
Abdominal 2
Axilla 1
Distant organ (n = 7)
Lung 4
Liver 1
Bone 1
Abdominal wall 1
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rence site is presented in Table II. The initial recurrence
was found in the cervical lymph node in 11 patients.
After receiving radiotherapy for the recurrence in the
cervical node, 3 patients were still alive more than 3
years.
The 5-year survival of the 63 patients who underwent
an operation for primary therapy was 26.7%. All 6
patients who received preoperative chemotherapy for
intramural metastasis died with recurrence within 24
months. The 5-year survivals of these 63 patients, as
compared with the factors listed earlier, are given in
Table III. There was no statistically significant differ-
ence between the postoperative survival curves when
compared according to the location of the tumors (Fig
Fig 1. Survival curves expressed according to the Kaplan-Meier method based on tumor location in patients with
clinically positive cervical nodes. Vertical bars depict 95% confidence limits, and the table at the bottom indi-
cates the number of patients at risk at the points.
Table III. The 5-year survivals by the Kaplan-Meier method and the multivariable analysis by the Cox proportional
hazards model, compared according to the factors of the patients treated with an operation for thoracic esophageal
carcinoma with clinically positive cervical node involvement (1987-1995; n = 63)
Multivariable analysis
n Five-year survival (%) P value Hazard ratio 95% Confidence limits
Tumor location .6
Upper 13 23.1
Middle 44 27.5 .8 1.084 0.414-2.838
Lower 6 33.3 .4 1.782 0.404-7.848
T categories .02
T1 8 87.5 .005 0.032 0.003-0.359
T2 6 66.7 .01 0.110 0.020-0.599
T3 46 13.7 .04 0.261 0.072-0.938
T4 3 0
Subdivisions of N categories .19
N1a (1-3 nodes involved) 20 46.2 .18 0.529 0.210-1.334
N1b (4-7 nodes involved) 14 28.6 .10 0.521 0.237-1.145
N1c (>7 nodes involved) 29 11.5
Abdominal node involvement
Negative 30 35.6 .9 1.014 0.384-2.677
Positive 33 17.7
Residual tumor classification
R0 (no residual tumor) 49 34.3 <.0001 5.522 2.542-11.996
R1, R2 (residual tumor) 14 0
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1). The patients with less tumor invasion had a better
chance of survival (Fig 2). The patients with tumor
invading adjacent structures (T4) had statistically less
chance of survival than those without. There was no
statistical difference in survival on the basis of the
number of involved nodes (Fig 3). The patients without
abdominal node involvement had better survivals on
the basis of univariate analysis (Fig 4). However, even
the patient with the worst factors had a chance of sur-
viving for 5 years after the operation, and it is apparent
that those were not important prognostic factors by
multivariable analysis (Table III). Analysis revealed the
most statistically significant difference between the
patients who received resection without residual tumor
Fig 3. Survival curves expressed according to the Kaplan-Meier method based on subdivisions of N categories
classified by the number of involved nodes according to the supplement of the TNM classification in patients with
clinically positive cervical nodes (N1a, 1-3 nodes involved; N1b, 4-7 nodes involved; N1c, more than 7 nodes
involved). Vertical bars depict 95% confidence limits, and the table at the bottom indicates the number of patients
at risk at the points.
Fig 2. Survival curves expressed according to the Kaplan-Meier method based on T categories according to the
TNM classification in patients with clinically positive cervical nodes. Vertical bars depict 95% confidence lim-
its, and the table at the bottom indicates the number of patients at risk at the points.
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and those who did with residual tumor (Fig 5).
Multivariable analysis revealed a significant difference
between the patients who received curative resection
(R0) and those who did not.
Discussion
The high incidence of cervical lymph node involvement
in patients with thoracic esophageal carcinoma is well
known. In our series of investigation, 121 patients (19.1%)
of 633 patients with thoracic esophageal carcinoma had
clinically positive cervical node involvement by pretreat-
ment examination. Altorki and Skinner2 recently reported
that cervical nodal metastasis occurred irrespective of
tumor location or T status, even in adenocarcinoma of the
esophagus. Also in our series, patients in whom the tumor
was in the lower esophagus and the tumor invasion was
Fig 4. Survival curves expressed according to the Kaplan-Meier method based on the existence of abdominal
node involvement as an index of wide lymphatic spread in patients with clinically positive cervical nodes. Vertical
bars depict 95% confidence limits, and the table at the bottom indicates the number of patients at risk at the
points.
Fig 5. Survival curves expressed according to the Kaplan-Meier method based on R categories of residual tumor
classification according to the TNM classification in patients who underwent an operation. A statistically signif-
icant difference was observed between survival curves of the patients who received curative resection (no resid-
ual tumor) and those who did not (residual tumor). Vertical bars depict 95% confidence limits, and the table at
the bottom indicates the number of patients at risk at the points.
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limited to within the submucosal layer (T1) had clinically
positive cervical nodal metastasis.
From our experience of extensive lymph node dissec-
tion, including the neck, for the patients with
esophageal carcinoma, it is thought that dissection of
the involved cervical node might provide the possibility
for radical cure. The 5-year survival of the 63 patients
who underwent an operation was 26.7%. This indicates
that some of the patients with cervical involvement
were at a stage that was not too late for undergoing an
operation. We examined the prognostic factors to deter-
mine the indications for surgical intervention for the
patients with cervical involvement. In the TNM classi-
fication, cervical node involvement was classified as
M1a for the patients with a tumor in the upper thoracic
esophagus and M1b for those with tumors in the mid-
dle and lower esophagus. However, there was no statis-
tically significant difference between the postoperative
survival of the patients with cervical involvement when
compared according to the location of the tumors.
When survival was compared according to the factors
outlined by the TNM classification and the 1993 sup-
plement, patients with the tumor invading more and
patients with more involved nodes had worse survivals.
As a matter of course, it means that the patients with
later stages of the disease had worse survival. The
patients with transmural tumors (T3 or T4) had a sur-
vival at 5 years of less than 15%. In contrast, there is a
dramatic 5-year survival seen in patients with T1 or T2
tumors. Similarly, patients with preoperative evidence
of extensive lymph node involvement (N1C disease)
were given their overall poor 5-year survival. However,
multivariable analysis revealed a significant difference
in the patients with tumor invading adjacent structures
(T4; only 3 of 63 patients). Multivariable analysis
revealed a significant difference between the patients
who received curative resection (R0) and those who did
not. Other factors did not exclude the necessity for sur-
gical intervention.
Of 49 patients who underwent curative operations,
the initial recurrence was found in the lymph node in
19 patients and in the cervical lymph node in 11
patients. This indicates the difficulty of sugical com-
plete dissection for lymphatic spread. The lymph node
spread ends nowhere, and the tumor extends into perin-
odal fat tissues around the adjacent organs. However,
these patients who underwent radical operations had a
34.3% 5-year survival after the operation. Even when
the patients had clinically positive cervical nodes from
thoracic esophageal carcinoma, they had a possibility
of long-term survival after curative resection with neck
lymph node dissection. An operation is thus indicated
for curative intent. A radical operation was attempted
in 63 patients; however, an operation without residual
tumor was accomplished in 49 patients. Accurate pre-
treatment evaluation is important for deciding which
patients require an operation and how to carry out a
curative surgical procedure.
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